Bluebird Bio Company

Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.

Invests into

Technology: CAR-T
Industry: Gene therapy
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1993-01-01
Employees Number: 501-1000
Funding Status: IPO
Investors Number: 13
Total Funding: 1229839236
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-09-08
Last Funding Type: Post-IPO Equity

Visit Website
info@bluebirdbio.com
http://twitter.com/bluebirdbio
Register and Claim Ownership